HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Daniel L. Miller Mark S. Allen Claude Deschamps Victor F. Trastek Peter C. Pairolero Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Billing, P. S. Articles by Pairolero, P. C. Search for Related Content PubMed PubMed Citation Articles by Billing, P. S. Articles by Pairolero, P. C. Related Collections Lung - cancer

J Thorac Cardiovasc Surg 2001;122:548-553
© 2001 The American Association for Thoracic Surgery

General Thoracic Surgery (GTS)

Surgical treatment of primary lung cancer with synchronous brain metastases

From the Division of General Thoracic Surgery, Mayo Clinic and Foundation, Rochester, Minn.

Received for publication April 22, 1999. Revisions requested June 9, 1999; revisions received Feb 22, 2001. Accepted for publication Feb 27, 2001. Address for reprints: Daniel L. Miller, MD, Division of General Thoracic Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (E-mail: miller.danielmd{at}mayo.edu).

Abstract

Objectives: The role of surgical resection for brain metastases from non–small cell lung cancer is evolving. Although resection of primary lung cancer and metachronous brain metastases is superior to other treatment modalities in prolonging survival and disease-free interval, resection of the primary non–small cell lung cancer and synchronous brain metastases is controversial.
Methods: From January 1975 to December 1997, 220 patients underwent surgical treatment for brain metastases from non–small cell lung cancer at our institution. Twenty-eight (12.7%) of these patients underwent surgical resection of synchronous brain metastases and the primary non–small cell lung cancer.
Results: The group comprised 18 men and 10 women. Median age was 57 years (range 35-71 years). Twenty-two (78.6%) patients had neurologic symptoms. Craniotomy was performed first in all 28 patients. Median time between craniotomy and thoracotomy was 14 days (range 4-840 days). Pneumonectomy was performed in 4 patients, bilobectomy in 4, lobectomy in 18, and wedge excision in 2. Postoperative complications developed in 6 (21.4%) patients. Cell type was adenocarcinoma in 11 patients, squamous cell carcinoma in 9, and large cell carcinoma in 8. After pulmonary resection, 17 patients had no evidence of lymph node metastases (N0), 5 had hilar metastases (N1), and 6 had mediastinal metastases (N2). Twenty-four (85.7%) patients received postoperative adjuvant therapy. Follow-up was complete in all patients for a median of 24 months (range 2-104 months). Median survival was 24 months (range 2-104). Survival at 1, 2, and 5 years was 64.3%, 54.0%, and 21.4%, respectively. The presence of thoracic lymph node metastases (N1 or N2) significantly affected 5-year survival (P = .001).
Conclusion: Although the overall survival for patients who have brain metastases from non–small cell lung cancer is poor, surgical resection may prove beneficial in a select group of patients with synchronous brain metastases and lung cancer without lymph node metastases.

This article has been cited by other articles:

				T. L. Demmy and C. Nwogu Is Video-Assisted Thoracic Surgery Lobectomy Better? Quality of Life Considerations Ann. Thorac. Surg., February 1, 2008; 85(2): S719 - S728. [Abstract] [Full Text] [PDF]

				R. F. Munden, S. S. Swisher, C. W. Stevens, and D. J. Stewart Imaging of the Patient with Non-Small Cell Lung Cancer Radiology, December 1, 2005; 237(3): 803 - 818. [Abstract] [Full Text] [PDF]

				V. Getman, E. Devyatko, D. Dunkler, F. Eckersberger, A. End, W. Klepetko, G. Marta, and M. R. Mueller Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 1107 - 1113. [Abstract] [Full Text] [PDF]

				D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al. American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353. [Full Text] [PDF]